Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

June 6, 2023

Rani, Celltrion expand partnership for development of adalimumab biosimilar

Rani Therapeutics has expanded its collaboration with Celltrion for developing RT-105, an orally administered adalimumab biosimilar.

Rani, Celltrion expand partnership for development of adalimumab biosimilar